FDA to Host Public Workshop on Platelet Transfusion Products and Substitutes

Summary

The US Food and Drug Administration (FDA) will host a public workshop to evaluate the in vivo efficacy of platelet transfusion products and platelet substitutes, building on the agency's ongoing efforts to improve transfusion safety and effectiveness.